Get the Stockscreener App
7.33
0.69%
0.05
After Hours:
7.35
0.02
+0.27%
Aurinia Pharmaceuticals Inc stock is traded at $7.33, with a volume of 912.98K.
It is up +0.69% in the last 24 hours and up +7.64% over the past month.
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.
See More
Previous Close:
$7.28
Open:
$7.24
24h Volume:
912.98K
Relative Volume:
0.66
Market Cap:
$1.04B
Revenue:
$175.51M
Net Income/Loss:
$-78.02M
P/E Ratio:
-13.83
EPS:
-0.53
Net Cash Flow:
$-34.18M
1W Performance:
+5.01%
1M Performance:
+7.64%
6M Performance:
+46.31%
1Y Performance:
-5.66%
1-Day Range:
$7.215
$7.445
1-Week Range:
$6.805
$7.445
52-Week Range:
$4.71
$10.05
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
Name
Aurinia Pharmaceuticals Inc
Sector
Industry
Phone
250-744-2487
Address
#140, 14315 - 118 AVENUE, EDMONTON, BC
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-22 | Downgrade | Oppenheimer | Outperform → Perform |
| May-05-22 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-10-21 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-28-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-25-21 | Reiterated | H.C. Wainwright | Buy |
| Nov-03-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-17-20 | Initiated | BTIG Research | Buy |
| May-05-20 | Initiated | Cowen | Outperform |
| Jan-10-20 | Initiated | Jefferies | Buy |
| Dec-16-19 | Reiterated | H.C. Wainwright | Buy |
| Mar-16-18 | Reiterated | Cantor Fitzgerald | Overweight |
| Feb-08-18 | Initiated | RBC Capital Mkts | Outperform |
| Oct-30-17 | Reiterated | H.C. Wainwright | Buy |
| May-18-17 | Reiterated | H.C. Wainwright | Buy |
| Apr-11-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-22-17 | Reiterated | FBR & Co. | Outperform |
| Dec-30-16 | Reiterated | H.C. Wainwright | Buy |
| Aug-17-16 | Reiterated | H.C. Wainwright | Buy |
| Jun-30-16 | Initiated | H.C. Wainwright | Buy |
| May-08-15 | Initiated | MLV & Co | Buy |
View All
Aurinia Pharmaceuticals Inc Stock (AUPH) Latest News
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Sees Large Decline in Short Interest - MarketBeat
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Could Be Less Than A Year Away From Profitability - Yahoo Finance
Armistice Capital LLC Sells 1,124,000 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat
Japan approves Aurinia's lupus nephritis treatment By Investing.com - Investing.com Australia
Japan approves Aurinia's lupus nephritis treatment By Investing.com - Investing.com Canada
Aurinia Announces Japan Approval of LUPKYNIS® (Voclosporin) to Treat Lupus Nephritis - BioSpace
Japan approves Aurinia's lupus nephritis treatment - Investing.com
Aurinia’s Lupus Drug LUPKYNIS Wins Approval in Japan - TipRanks
Aurinia Pharma Gets Approval in Japan for Lupus Treatment - MarketWatch
Aurinia Announces Japan Approval of LUPKYNIS® (Voclosporin) to Treat Lupus Nephritis - Yahoo Finance
Unum Group stock rises Thursday, still underperforms market - MarketWatch
Health Care Lags Market on Cyclical BiasHealth Care Roundup - MarketWatch
Waterloo Capital L.P. Decreases Stake in Ulta Beauty, Inc. (NASDAQ:ULTA) - Defense World
Universal Health Up 23% in 3 Months: Time to Buy or Miss the Boat? - Zacks Investment Research
3 Small Biotech Stocks With The 'Big Mo' Right Now - Seeking Alpha
Leuthold Group LLC Invests $2.76 Million in Urban Outfitters, Inc. (NASDAQ:URBN) - Defense World
Urban Outfitters Q2 2025 Scare Led To A More Fairly Priced Stock. Still A Hold But More Interesting - Seeking Alpha
Aurinia Pharmaceuticals: LUPKYNIS Leading The Way In Lupus Nephritis Treatment - Seeking Alpha
Oppenheimer Asset Management Inc. Grows Stock Position in Ulta Beauty, Inc. (NASDAQ:ULTA) - Defense World
Unitedhealth Group Inc [UNH] gain 10.29% so far this year. What now? - The DBT News
Unum Stock: Core Business Strength Comes Into Greater Focus (UNM) - Seeking Alpha
Allurion Technologies Inc. (NYSE:ALUR) Short Interest Up 8.6% in August - Defense World
UnitedHealth Group Incorporated (UNH): Hedge Funds Are Bullish On This Counter Cyclical and Defensive Stock to Invest In - Yahoo Finance
Alliance Global Partners’s latest rating for UMH stock - Knox Daily
Universal Music shares retain buy rating, price target steady on growth targets - Investing.com
Urban Outfitters (NASDAQ:URBN) Trading Up 4.1% - Defense World
Cantor Fitzgerald upgrades Universal Health Services, Inc. (UHS) stock to a Neutral - Knox Daily
UroGen Pharma reiterates stock target, outperform on strong FDA prospects - Investing.com
Analyzing the Impact of Earnings Reports on Unitedhealth Group Inc Inc. (UNH) Price Performance - The InvestChronicle
Amedisys sale to UnitedHealth unlikely to be done until at least end of November - MSN
UroGen Pharma Ltd (URGN) gets rating Initiated from Guggenheim - Knox Daily
Ratio Analysis: Unpacking Unitedhealth Group Inc (UNH)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
'49% stake...' Acquisition update from Aurobindo PharmaDetails - ET Now
Unitedhealth Group Inc [UNH] Stock sold by Insider ROOS THOMAS E for $1.62 million - Knox Daily
Oppenheimer & Co. Inc. Acquires 530 Shares of United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Aurobindo Pharma arm receives EIR from USFDA for Andhra Unit; stock down 2% - Business Standard
Aurinia Pharmaceuticals: This Recovery Can Continue (AUPH) - Seeking Alpha
United Homes Group (NASDAQ:UHG) Stock Price Down 1.1% - Defense World
Aurinia Pharmaceuticals (NASDAQ:AUPH) Rating Reiterated by Cantor Fitzgerald - Defense World
Ultimate Products Advances Share Buyback Plan - TipRanks
UnitedHealth Group (NYSE:UNH) Eyes Growth with Goodwill Partnership Amidst Cybersecurity and Financial Challenges - Yahoo Finance
Aurinia Pharmaceuticals Inc (AUPH)’s stock price range in the last year - US Post News
Universal Music Group is targeting 8-10% annual growth in subscription streaming revenues. Here’s how that might play out. - Music Business Worldwide
UnitedHealth Group (NYSE:UNH) Given “Overweight” Rating at Cantor Fitzgerald - Defense World
UMG: new targets set to 2028 - Marketscreener.com
Universal Health Services: Stock Has Lots Of Upside Runway (NYSE:UHS) - Seeking Alpha
UnitedHealth Group (UNH) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
Unum Group stock outperforms competitors on strong trading day - MarketWatch
Aurinia Pharmaceuticals (NASDAQ:AUPH) Trading 4% Higher - MarketBeat
What the Options Market Tells Us About UnitedHealth Group - Benzinga
Aurinia Pharmaceuticals (NASDAQ:AUPH) Earns "Overweight" Rating from Cantor Fitzgerald - MarketBeat
Aurinia Pharmaceuticals Inc Stock (AUPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):